We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Total compensation is similar to the industry average 10x Genomics' EPS grew by 34% over the past three years while total shareholder loss over the past three years was 89% The underwhelming share price performance of 10x Genomics, Inc. NASDAQ:TXG ) in the past three years would have disappointed many shareholders. However, what is unusual is that EPS growth has been positive, suggesting that the share price has diverged from fundamentals. These are some of the concerns that shareholders may want to bring up at the next AGM held on 11th of June. Voting on resolutions such as executive remuneration and other matters could also be a way to influence management. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment. Check out our latest analysis for 10x Genomics How Does Total Compensation For Serge Saxonov Compare With Other Companies In The Industry? Our data indicates that 10x Genomics, Inc. has a market capitalization
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics: Sticking To The Plan To Avoid The Falling The Knife [Seeking Alpha]Seeking Alpha
- Cityview Acquires Bay Area Multifamily Project [Yahoo! Finance]Yahoo! Finance
- 10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways PanelPR Newswire
- SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of 10x Genomics, Inc. (NASDAQ: TXG) and Encourages Investors to Contact the FirmAccesswire
- Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication [Yahoo! Finance]Yahoo! Finance
TXG
Earnings
- 4/30/24 - Miss
TXG
Sec Filings
- 6/20/24 - Form 8-K
- 6/13/24 - Form 4
- 6/13/24 - Form 4
- TXG's page on the SEC website